Trial intelligence / Profile preview

Intraoperative intravenous nefopam to reduce morphine consumption after total laparoscopic hysterectomy

TCTR20250521006Phase 3Not yet recruiting

Sponsor
Faculty of Medicine, Prince of Songkhla University
Start
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial in postoperative pain comparing Nefopam arm with Placebo arm (2 arms). Primary endpoint: Postoperative morphine consumption. Planned start Aug 2025; status: not yet recruiting.

02

Drugs

nefopam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on TCTR20250521006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250521006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call